To investigate the risk of injury in patients with Ménière’s disease (MD) and the effects of treatment.
Study Design
Population-based retrospective cohort study.
Setting
Data were collected from the Longitudinal Health Insurance Database 2005, containing the information of 2 million randomly selected individuals in Taiwan.
Methods
We enrolled 90,481 patients with newly diagnosed MD between 2000 and 2017 and 361,924 matched individuals without MD. The study outcomes were diagnoses of all-cause injuries. The Kaplan-Meier method was used to determine the cumulative incidence rates of injury in the MD and non-MD cohorts, and a log-rank test was used to analyze the differences between the cohorts. Cox proportional hazards models were used to calculate the 18-year hazard ratios of each cohort.
Results
A total of 80,151 patients were diagnosed with injuries during the follow-up period: 24,031 and 56,120 from the MD and non-MD cohorts, respectively. The adjusted hazard ratio (aHR) was 2.19 (95% CI, 2.16-2.35) after adjusting for demographic characteristics and comorbidities. Subgroup analysis revealed that MD was associated with an increased incidence of unintentional and intentional injuries (aHR, 2.24 [95% CI, 2.21-2.41] and 2.05 [95% CI, 2.01-2.19], respectively). Treatment with diuretics, antivertigo medications, or surgery did not reduce the risk of injury (aHR, 0.98 [95% CI, 0.59-1.54], 0.94 [95% CI, 0.58-1.50], and 0.99 [95% CI, 0.61-1.54]).
Conclusion
MD is independently associated with an increased risk of injuries. Medical or surgical treatment for MD does not reduce the risk of injury in patients with MD. Physicians should counsel patients with MD regarding preventive measures for avoiding subsequent injuries.
ChristopherLHWilkinsonEP.Ménière’s disease: medical management, rationale for vestibular preservation and suggested protocol in medical failure. Am J Otolaryngol. 2021;42(1):102817. doi:10.1016/j.amjoto.2020.102817
AlexanderTHHarrisJP.Current epidemiology of Ménière’s syndrome. Otolaryngol Clin North Am. 2010;43(5):965-970. doi:10.1016/j.otc.2010.05.001
4.
HarrisJPAlexanderTH.Current-day prevalence of Ménière’s syndrome. Audiol Neurootol. 2010;15(5):318-322. doi:10.1159/000286213
5.
NeuhauserHK.Epidemiology of vertigo. Curr Opin Neurol. 2007;20(1):40-46. doi:10.1097/WCO.0b013e328013f432
6.
WatanabeYMizukoshiKShojakuHWatanabeIHinokiMKitaharaM.Epidemiological and clinical characteristics of Ménière’s disease in Japan. Acta Otolaryngol Suppl. 1995;519:206-210. doi:10.3109/00016489509121906
7.
BasuraGJAdamsMEMonfaredA, et al. Clinical practice guideline: Ménière’s disease. Otolaryngol Head Neck Surg. 2020;162(2):S1-S55. doi:10.1177/0194599820909438
8.
ShojakuHWatanabeYFujisakaM, et al. Epidemiologic characteristics of definite Ménière’s disease in Japan: a long-term survey of Toyama and Niigata prefectures. ORL J Otorhinolaryngol Relat Spec. 2005;67(5):305-309. doi:10.1159/000089413
9.
YangTHXirasagarSChengYFWuCSKuoNWLinHC.Peripheral vestibular disorders: nationwide evidence from Taiwan. Laryngoscope. 2021;131(3):639-643. doi:10.1002/lary.28877
10.
HuppertDStruppMBrandtT.Long-term course of Ménière’s disease revisited. Acta Otolaryngol. 2010;130(6):644-651. doi:10.3109/00016480903382808
11.
HaviaMKentalaE.Progression of symptoms of dizziness in Ménière’s disease. Arch Otolaryngol Head Neck Surg. 2004;130(4):431-435. doi:10.1001/archotol.130.4.431
12.
Perez-GarriguesHLopez-EscamezJAPerezP, et al. Time course of episodes of definitive vertigo in Ménière’s disease. Arch Otolaryngol Head Neck Surg. 2008;134(11):1149-1154. doi:10.1001/archotol.134.11.1149
13.
StahleJFribergUSvedbergA.Long-term progression of Ménière’s disease. Acta Otolaryngol Suppl. 1991;485:78-83. doi:10.3109/00016489109128047
14.
HaviaMKentalaEPyykkoI.Prevalence of Ménière’s disease in general population of southern Finland. Otolaryngol Head Neck Surg. 2005;133(5):762-768. doi:10.1016/j.otohns.2005.06.015
15.
SharonJD.A patient primer on vertigo-spinning out of control. JAMA Otolaryngol Head Neck Surg. 2021;147(12):1124. doi:10.1001/jamaoto.2021.1680
16.
BasuraGJLinGCTelianSA.Comparison of second-echelon treatments for Ménière’s disease. JAMA Otolaryngol Head Neck Surg. 2014;140(8):754-761. doi:10.1001/jamaoto.2014.1249
17.
TumarkinA.The otolithic catastrophe: a new syndrome. Br Med J. 1936;1:175-177.
18.
VibertDCaversaccioMHauslerR.Ménière’s disease in the elderly. Otolaryngol Clin North Am. 2010;43(5):1041-1046. doi:10.1016/j.otc.2010.05.009
19.
BallesterMLiardPVibertDHauslerR.Ménière’s disease in the elderly. Otol Neurotol. 2002;23(1):73-78. doi:10.1097/00129492-200201000-00017
20.
LeeKVijayendraVKBedriEHHonnurappaVRedleafM.Concerns of patients with Ménière disease in Ethiopia, India, and the United States. JAMA Otolaryngol Head Neck Surg. 2020;146(5):496-497. doi:10.1001/jamaoto.2019.2663
21.
HulseRBiesdorfAHormannK, et al. Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. Otol Neurotol. 2019;40(1):88-95. doi:10.1097/MAO.0000000000002013
22.
FigtreeWVCMenantJCChauATHubnerPPLordSRMigliaccioAA. Prevalence of vestibular disorders in independent people over 50 that experience dizziness. Front Neurol. 2021;12:658053. doi:10.3389/fneur.2021.658053
23.
MurdinLSchilderAG.Epidemiology of balance symptoms and disorders in the community: a systematic review. Otol Neurotol. 2015;36(3):387-392. doi:10.1097/MAO.0000000000000691
24.
StruppMMandalaMLopez-EscamezJA.Peripheral vestibular disorders: an update. Curr Opin Neurol. 2019;32(1):165-173. doi:10.1097/WCO.0000000000000649
25.
PfaltzCRKamathR.The problem of central compensation of peripheral vestibular dysfunctions. Acta Otolaryngol. 1971;71(2):266-272. doi:10.3109/00016487109125362
26.
SchlickCSchnieppRLoidlVWuehrMHesselbarthKJahnK.Falls and fear of falling in vertigo and balance disorders: a controlled cross-sectional study. J Vestib Res. 2016;25(5-6):241-251. doi:10.3233/VES-150564
27.
KimHLeeSKimJ.Risk of injury after emergency department visit for acute peripheral vertigo: a matched-cohort study. Clin Exp Emerg Med. 2020;7(3):176-182. doi:10.15441/ceem.19.064
28.
LinHCXirasagarSWangCHChengYFLiuTCYangTH.A nationwide population-based study on the association between land transport accident and peripheral vestibular disorders. Int J Environ Res Public Health. 2021;18(12):6570. doi:10.3390/ijerph18126570
29.
AlexanderBHRivaraFPWolfME.The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health. 1992;82(7):1020-1023. doi:10.2105/ajph.82.7.1020
30.
SterlingDAO’ConnorJABonadiesJ.Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma. 2001;50(1):116-119. doi:10.1097/00005373-200101000-00021
31.
KwanMMCloseJCWongAKLordSR.Falls incidence, risk factors, and consequences in Chinese older people: a systematic review. J Am Geriatr Soc. 2011;59(3):536-543. doi:10.1111/j.1532-5415.2010.03286.x
32.
PyykkoIManchaiahVZouJLevoHKentalaE.Driving habits and risk of traffic accidents among people with Ménière’s disease in Finland. J Int Adv Otol. 2019;15(2):289-295. doi:10.5152/iao.2019.5915
33.
AtzemaCLGrewalKLuHKapralMKKulkarniGAustinPC.Outcomes among patients discharged from the emergency department with a diagnosis of peripheral vertigo. Ann Neurol. 2016;79(1):32-41. doi:10.1002/ana.24521
34.
YangTHXirasagarSChengYFWangCHLinHC.Increased risk of injury following a diagnosis of vertigo: a population-based study. Laryngoscope. 2021;131(7):1633-1638. doi:10.1002/lary.29519
35.
ArenbergIKCountrymanLFBernsteinLHShambaughGEJr.Van Gogh had Ménière’s disease and not epilepsy. JAMA. 1990;264(4):491-493.
36.
PyykkoIManchaiahVZouJLevoHKentalaE.Impact of Tumarkin attacks on complaints and work ability in Ménière’s disease. J Vestib Res. 2018;28(3-4):319-330. doi:10.3233/VES-180634
37.
PyykkoIManchaiahVZouJLevoHKentalaE.Association between syncope and Tumarkin attacks in Ménière’s disease. J Int Adv Otol. 2019;15(1):135-140. doi:10.5152/iao.2019.6094
38.
OdkvistLMBergeniusJ.Drop attacks in Ménière’s disease. Acta Otolaryngol Suppl. 1988;455:82-85. doi:10.3109/00016488809125064
39.
BalohRWJacobsonKWinderT.Drop attacks with Ménière’s syndrome. Ann Neurol. 1990;28(3):384-387. doi:10.1002/ana.410280314
40.
DobbelsBLucieerFMertensG, et al. Prospective cohort study on the predictors of fall risk in 119 patients with bilateral vestibulopathy. PLoS One. 2020;15(3):e0228768. doi:10.1371/journal.pone.0228768
41.
SchnieppRSchlickCSchenkelF, et al. Clinical and neurophysiological risk factors for falls in patients with bilateral vestibulopathy. J Neurol. 2017;264(2):277-283. doi:10.1007/s00415-016-8342-6
42.
WardBKAgrawalYHoffmanHJCareyJPDella SantinaCC.Prevalence and impact of bilateral vestibular hypofunction: results from the 2008 US National Health Interview Survey. JAMA Otolaryngol Head Neck Surg. 2013;139(8):803-810. doi:10.1001/jamaoto.2013.3913
43.
HerssensNHowDvan de BergRMcCrumC.Falls among people with bilateral vestibulopathy: a review of causes, incidence, injuries, and methods. JAMA Otolaryngol Head Neck Surg. 2022;148(2):187-192. doi:10.1001/jamaoto.2021.3673
44.
HuppertDStraubeAAlbersLvon KriesRObermeierV.Risk of traffic accidents after onset of vestibular disease assessed with a surrogate marker. J Neurol. 2019;266(suppl 1):3-8. doi:10.1007/s00415-019-09300-5
45.
ChitmeHRAl-KashmiriAAl-ThehliHMAl-QanoobiMJAl-MushefriMMVenuvgopalJ.Impact of medical conditions and medications on road traffic safety. Oman Med J. 2018;33(4):316-321. doi:10.5001/omj.2018.58
46.
WeiEXAgrawalY.Association between vestibular vertigo and motor vehicle accidents: data from the 2016 National Health Interview Survey. Ear Hear. 2018;39(6):1232-1235. doi:10.1097/AUD.0000000000000602
47.
AlyonoJC.Vertigo and dizziness: understanding and managing fall risk. Otolaryngol Clin North Am. 2018;51(4):725-740. doi:10.1016/j.otc.2018.03.003
48.
ChenFPHuangTSFuTSSunCCChaoASTsaiTL.Secular trends in incidence of osteoporosis in Taiwan: a nationwide population-based study. Biomed J. 2018;41(5):314-320. doi:10.1016/j.bj.2018.08.001
49.
ChangCBYangRSChangLY, et al. Fracture types affect clinical outcomes of patients managed within the fracture liaison and osteoporosis medication management services. Sci Rep. 2019;9(1):10089. doi:10.1038/s41598-019-46315-4
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
